DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Botox (Botulinum Toxin Type A) - News

 



News related to Botox (Botulinum Toxin Type A) and/or conditions it is approved for

The Lowe Law Firm Files Suit Over Alleged Botox Overdose
Source: Cosmetic Medicine / Plastic Surgery News From Medical News Today [2009.11.09]
St. Louis-based The Lowe Law Firm has filed a lawsuit on behalf of a man who experienced partial respiratory paralysis and other side effects after receiving an overdose of the Botox being used to treat his muscle spasticity. The suit, Richard A. Hart v. Yi Pan, Tenet HealthSystem SL Inc., d/b/a St. Louis University Hospital and Allergan USA Inc., cause no. 0922-CC09485, was filed in St. Louis Circuit Court on Oct. 21.

Botox as a Breast Lift?
Source: MedicineNet Human Immunodeficiency Virus (HIV, AIDS) Specialty [2009.10.27]
Title: Botox as a Breast Lift?
Category: Health News
Created: 10/27/2009 10:02:00 AM
Last Editorial Review: 10/27/2009 10:02:27 AM

Cleavage Rejuvenation, Do-It-Yourself Lasers, Botox® Breast Lift - Hype Or Reality?
Source: Cosmetic Medicine / Plastic Surgery News From Medical News Today [2009.10.26]
Whether their effectiveness is fact or fiction, less invasive cosmetic procedures such as cleavage rejuvenation, do-it-yourself (DIY) cosmetic therapies, and using Botox® to "lift" the breasts are making headlines, but are they safe? Plastic surgeons are discussing if these, and more, are cutting edge new discoveries or just "buyer beware" marketing hype at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2009 conference, Oct. 23 - 27, in Seattle.

Scientific Studies Confirm The Value Of Botulinum Toxin Type A (Botox) In Treating And Preventing Chronic Migraine
Source: Headache / Migraine News From Medical News Today [2009.09.16]
Four separate studies[i] representing the findings of clinical trials in the U.S., Canada and Europe have confirmed the value of onabotulinumtoxinA in treating and preventing chronic migraine in adults. These studies found that treatment with botulinum toxin type A was associated with significantly fewer headache days, less headache-related disability, and significantly improved quality of life.

Dysport, a Botox Competitor, Approved
Source: MedicineNet Botulism Specialty [2009.05.01]
Title: Dysport, a Botox Competitor, Approved
Category: Health News
Created: 5/1/2009 2:00:00 AM
Last Editorial Review: 5/1/2009

Black Box Warning for Botox
Source: MedicineNet Botulism Specialty [2009.05.01]
Title: Black Box Warning for Botox
Category: Health News
Created: 5/1/2009
Last Editorial Review: 5/1/2009

FDA Checks Reports of Botox Risks
Source: MedicineNet Botulism Specialty [2008.02.11]
Title: FDA Checks Reports of Botox Risks
Category: Health News
Created: 2/11/2008
Last Editorial Review: 2/11/2008

News From Plastic Surgery 2009
Source: Cosmetic Medicine / Plastic Surgery News From Medical News Today [2009.10.26]
Botox Takes a Shot at Pain No longer just a wrinkle fighter, Botox® may have indications as a pain medication to fight Chronic Regional Pain Syndrome (CRPS), reports a new study presented at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2009 conference, Oct. 23-27, in Seattle. Between 5 and 26 people out of every 100,000 have their lives significantly disrupted by some form of chronic pain.

Merz Pharmaceuticals Announces Approval Of Post-stroke Upper Limb Spasticity Indication For Xeomin(R) In The EU
Source: Clinical Trials / Drug Trials News From Medical News Today [2009.11.19]
Merz Pharmaceuticals announced Xeomin®, the first botulinum toxin type A free from complexing proteins has been granted an extension of indication for post-stroke spasticity of the upper limb presenting with flexed wrist and clenched fist in adults in various European countries. Xeomin® was already granted approval for post-stroke spasticity of the upper limb in early 2009 in Canada, Mexico and Argentina.

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009